Add like
Add dislike
Add to saved papers

Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes.

Anticancer Research 2003 November
Regional metastasis is an important prognostic factor for esophageal squamous cell carcinoma (ESCC). A reduced expression of cell adhesion molecules has been reported to be associated with tumor metastasis. However, the clinical significance of such adhesion molecules in metastatic lymph nodes remains unclear. The expression of adhesion molecules (E-cadherin, beta-catenin, CD44, CD44-v6 and Integrin beta 1) was studied in 71 primary tumors and their corresponding nodal metastases using immunohistochemical analyses. Regarding the clinicopathological features, a reduction in the expression of adhesion molecules in primary tumors was found to be significantly associated with the depth of invasion, lymph node metastasis, lymph and blood vessel permeations (p < 0.05). There was a significantly positive correlation between E-cadherin and beta-catenin (R = 0.55, p < 0.001), CD44 and CD44-v6 (R = 0.65, p < 0.001) in the primary tumor. In lymph node metastasis, there was significantly less staining for E-cadherin (p < 0.01), CD44 (p < 0.01), CD44-v6 (p < 0.05) and Integrin beta 1 (p < 0.01) in lymph node metastasis than in the primary tumor, and a significantly positive correlation between E-cadherin and beta-catenin (R = 0.55, p < 0.001). Regarding the number of lymph node metastases, a significant difference was found, and a reduced expression of E-cadherin, beta-catenin and CD44-v6 in the metastatic lymph nodes correlated with an increased number of lymph node metastases (p < 0.01). These findings are consistent with the idea that adhesion molecules have their own alterations, and a reduced expression of adhesion molecules in the metastatic lymph nodes correlated with an increased number of lymph node metastases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app